Long COVID Risk Higher for Autoimmune Disease Patients
Adults with autoimmune rheumatic diseases face a higher risk of long COVID, new research finds.
Updated on Oct. 21, 2026 in Arthritis
Live Poll
Do you feel new research on medical risks changes how you monitor your personal health?
A recent study indicates that adults with autoimmune rheumatic diseases face a higher risk of developing long COVID compared to those without these conditions. Findings published in Arthritis & Rheumatology highlight a significant disparity in long-term outcomes for these patients.
Why it matters
Understanding this elevated risk helps patients with autoimmune conditions and their healthcare providers better navigate post-COVID care. Managing underlying inflammatory conditions is crucial as researchers identify how these diseases influence long-term viral recovery.
A retrospective cohort study analyzed data from 187,106 matched patients, identifying a long COVID prevalence of 2.8% among those with autoimmune rheumatic diseases versus 1.5% in controls. The analysis indicates an adjusted hazard ratio of 1.56 for long COVID risk in the AIRD population.
The players
Arthritis & Rheumatology
A peer-reviewed journal that publishes medical research concerning autoimmune and rheumatic conditions.
The details
Researchers utilized data from the National Clinical Cohort Collaborative, comparing patients with autoimmune rheumatic diseases to matched controls using 1:1 propensity score matching. Beyond the baseline risk, the study noted that factors including acute COVID-19 severity, obesity, and pulmonary disease influence outcomes. Additionally, specific treatments such as rituximab or glucocorticoid exposure, as well as diagnoses like Sjögren syndrome, correlate with a higher likelihood of long COVID.
Timeline
October 14, 2026: The research was published in Arthritis & Rheumatology.
October 20, 2026: The findings are now available for clinical review.
Health Landscape
This research follows the methodology established by the National Clinical Cohort Collaborative to evaluate large-scale patient outcomes. It adds to the growing body of literature focused on how chronic inflammatory states modify long-term viral recovery.
If you have an autoimmune rheumatic disease, it is worth discussing your specific COVID-19 recovery concerns and any ongoing symptoms with your rheumatologist. Staying up to date on clinical research regarding your specific condition can help you prepare for informed conversations with your care team.
The takeaway
Patients with autoimmune rheumatic diseases have a 1.56 times higher risk for long COVID compared to those without. Tracking any persistent symptoms following an acute infection is a prudent habit to discuss with your primary physician or specialist.
Further reading
For more information on managing symptoms and ongoing research, visit Arthritis.
Live Poll
Do you feel new research on medical risks changes how you monitor your personal health?
